ExodusPoint Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-29,552
Closed -$81K 1572
2024
Q3
$81K Buy
+29,552
New +$81K ﹤0.01% 1404
2021
Q3
Sell
-42,042
Closed -$135K 2227
2021
Q2
$135K Buy
+42,042
New +$135K ﹤0.01% 2006
2019
Q2
Sell
-70,854
Closed -$362K 1160
2019
Q1
$362K Buy
70,854
+36,254
+105% +$185K 0.03% 408
2018
Q4
$119K Buy
+34,600
New +$119K 0.01% 295